نتایج جستجو برای: pulmonary embolism thrombolytic therapy anticoagulants

تعداد نتایج: 879318  

Journal: :Chest 2016
Clive Kearon Elie A Akl Joseph Ornelas Allen Blaivas David Jimenez Henri Bounameaux Menno Huisman Christopher S King Timothy A Morris Namita Sood Scott M Stevens Janine R E Vintch Philip Wells Scott C Woller Lisa Moores

BACKGROUND We update recommendations on 12 topics that were in the 9th edition of these guidelines, and address 3 new topics. METHODS We generate strong (Grade 1) and weak (Grade 2) recommendations based on high- (Grade A), moderate- (Grade B), and low- (Grade C) quality evidence. RESULTS For VTE and no cancer, as long-term anticoagulant therapy, we suggest dabigatran (Grade 2B), rivaroxaba...

2017
T. Lorjé N. Barlo C. L. A. Reichert W. de Kanter M. A. Sluman

A 46-year-old male with advanced adenocarcinoma of the lung presented with venous thrombosis. Despite anticoagulants, he developed a stroke and bowel ischaemia. Echocardiography revealed mobile structures on the mitral valve and at the pulmonary artery origin (Fig. 1). Although treatment for endocarditis and pulmonary embolism was initiated, his condition deteriorated. However, blood cultures r...

JC Sebatino K Woods RM Mango S Patil Simin Dadparvar, Y Dou

The clinical management of pulmonary embolism and deep venous thrombosis of the legs are similar and requires prolonged anticoagulation therapy. The standard diagnostic approach in patients suspected of pulmonary embolism is ventilation-perfusion (V/Q) lung scan and compression ultrasonography to detect deep venous thrombosis. This retrospective study analyzed the role of V/Q lung scan an...

Journal: :Italian heart journal : official journal of the Italian Federation of Cardiology 2005
Giancarlo Agnelli Cecilia Becattini

For the majority of patients with pulmonary embolism the recommended therapy consists of a 5 to 7 day treatment with heparin followed by a treatment with oral anticoagulants given for at least 3 months. The currently recommended duration of oral anticoagulant treatment for pulmonary embolism is the result of the balance between the benefit provided by treatment, essentially the prevention of re...

2011
Soon Jung Lee Young Cheol Weon Hee Jeong Cha Sun Young Kim Kwang Won Seo Yangjin Jegal Jong-Joon Ahn Seung Won Ra

Skull base osteomyelitis (SBO) is difficult to diagnose when a patient presents with multiple cranial nerve palsies but no obvious infectious focus. There is no report about SBO with septic pulmonary embolism. A 51-yr-old man presented to our hospital with headache, hoarseness, dysphagia, frequent choking, fever, cough, and sputum production. He was diagnosed of having masked mastoiditis compli...

Journal: :QJM : monthly journal of the Association of Physicians 2000
T Godfrey M A Khamashta G R Hughes

We have arbitrarily chosen our recommended W.-K. Chan reduced dosage of thrombolytic therapy as few T.-F. Chan studies address this issue. The largest study was by Division of Cardiology Goldhaber et al.6 comparing reduced rtPA bolus Department of Medicine & Geriatrics (0.6 mg/kg/15 min, maximum 50 mg) and rtPA infuUnited Christian Hospital sion (100 mg over 2 h) in 87 patients, a double-blind ...

Journal: :International journal of clinical and experimental medicine 2015
Hong Wang Yuan Huang Chun-Wei Xu Li Lin

OBJECTIVE To analyze the differences of the clinical characteristics and risk factors between tumor and non-tumor patients complicated with pulmonary embolism. METHODS A retrospective analysis was conducted on 96 hospitalized patients complicated with pulmonary embolism admitted into 307 Hospital of PLA from January 2009 to December 2014. 96 cases were divided into tumor group (n=52) and non-...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید